HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tasuku Harada Selected Research

Norethindrone (Norethisterone)

1/2017Efficacy of Norethisterone in Patients with Ovarian Endometrioma.
12/2016Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo-controlled, double-blind, randomized trial.
5/2011Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tasuku Harada Research Topics

Disease

47Endometriosis
01/2022 - 01/2002
26Neoplasms (Cancer)
02/2022 - 05/2002
13Dysmenorrhea (Menstrual Pain)
01/2022 - 11/2008
10Carcinoma (Carcinomatosis)
10/2021 - 05/2002
9Ovarian Neoplasms (Ovarian Cancer)
10/2021 - 03/2007
7Pain (Aches)
01/2022 - 03/2009
6Endometrial Neoplasms (Endometrial Cancer)
02/2022 - 05/2002
6Infertility (Sterility)
01/2019 - 01/2002
5Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021 - 04/2014
5Cysts
12/2017 - 01/2002
4Hemorrhage
08/2022 - 12/2007
4Premature Obstetric Labor (Premature Labor)
02/2022 - 02/2005
4Adenomyosis
02/2022 - 12/2017
4Pelvic Pain
01/2022 - 08/2015
3Venous Thrombosis (Deep-Vein Thrombosis)
02/2022 - 01/2020
3Metrorrhagia (Spotting)
01/2022 - 12/2007
3Ovarian Epithelial Carcinoma
01/2021 - 07/2011
3Inflammation (Inflammations)
01/2018 - 10/2007
3Adenocarcinoma
12/2015 - 02/2008
2Menorrhagia
08/2022 - 01/2022
2Venous Thromboembolism
01/2022 - 01/2020
2Headache (Headaches)
01/2022 - 01/2019
2Wounds and Injuries (Trauma)
01/2020 - 04/2004
2Weight Loss (Weight Reduction)
12/2019 - 03/2014
2Vomiting
08/2019 - 01/2019
2Nausea
08/2019 - 01/2019
2Infections
06/2016 - 10/2007
2Leiomyoma (Uterine Fibroids)
12/2009 - 03/2006
1Thrombosis (Thrombus)
02/2022
1Metaplasia
02/2022
1Fibrosis (Cirrhosis)
01/2022

Drug/Important Bio-Agent (IBA)

9Messenger RNA (mRNA)IBA
11/2019 - 01/2002
9Interleukin-6 (Interleukin 6)IBA
09/2019 - 01/2002
8Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2002
7Estrogens (Estrogen)FDA Link
02/2022 - 04/2005
6CytokinesIBA
01/2022 - 01/2002
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2019 - 10/2013
5Progestins (Progestagens)IBA
10/2021 - 05/2005
5Biomarkers (Surrogate Marker)IBA
10/2021 - 03/2007
5dienogestFDA Link
10/2021 - 12/2007
5Oral ContraceptivesIBA
11/2020 - 11/2008
5NF-kappa B (NF-kB)IBA
01/2018 - 05/2005
4Levonorgestrel (Plan B)FDA LinkGeneric
08/2022 - 04/2021
3fibrin fragment D (D-dimer)IBA
02/2022 - 01/2020
3Pharmaceutical PreparationsIBA
01/2022 - 01/2010
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2020 - 02/2003
3Estradiol (Delestrogen)FDA LinkGeneric
01/2019 - 12/2007
3LipopolysaccharidesIBA
11/2018 - 01/2010
3drospirenoneFDA LinkGeneric
11/2017 - 08/2015
3Norethindrone (Norethisterone)FDA LinkGeneric
01/2017 - 05/2011
3Analgesics (Analgesic Drugs)IBA
12/2016 - 11/2008
3Hormones (Hormone)IBA
11/2016 - 05/2005
3Aromatase (CYP19)IBA
01/2011 - 01/2008
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2009 - 01/2002
3InterleukinsIBA
10/2008 - 08/2003
3Interleukin-8 (Interleukin 8)IBA
10/2008 - 02/2003
2Estrogen ReceptorsIBA
10/2021 - 01/2016
2toki-shakuyaku-sanIBA
11/2020 - 11/2019
2ProgesteroneFDA LinkGeneric
01/2019 - 12/2007
2ORALIT (ORS)IBA
01/2019 - 01/2016
2TS 108IBA
11/2018 - 12/2017
2Bevacizumab (Avastin)FDA Link
11/2018 - 01/2017
2Selective Estrogen Receptor Modulators (SERM)IBA
11/2018 - 12/2017
2lipoarabinomannan (LAM)IBA
11/2018 - 04/2004
2Inhibitor of Apoptosis ProteinsIBA
01/2018 - 01/2015
2TabletsIBA
11/2017 - 01/2017
2Ethinyl Estradiol (Estinyl)FDA LinkGeneric
12/2016 - 05/2011
2Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
05/2015 - 06/2013
2SurvivinIBA
01/2015 - 12/2009
2dactolisibIBA
08/2014 - 03/2014
2Phosphatidylinositols (Phosphatidylinositol)IBA
03/2014 - 07/2012
2Cisplatin (Platino)FDA LinkGeneric
01/2014 - 07/2012
2Antineoplastic Agents (Antineoplastics)IBA
01/2014 - 07/2011
2Dinoprostone (PGE2)FDA Link
10/2013 - 01/2010
2Buserelin (Suprefact)IBA
01/2010 - 03/2009
2RetinoidsIBA
12/2008 - 02/2008
2keratinocyte growth factor receptorIBA
02/2008 - 02/2003
1ChromatinIBA
02/2022
1Rubber (Elastica)IBA
02/2022
1Hematoxylin (Haematoxylon)IBA
02/2022
1Enoxaparin (Lovenox)FDA LinkGeneric
02/2022
1Eosine Yellowish-(YS) (Eosin)IBA
02/2022
1Leuprolide (Lupron)FDA LinkGeneric
01/2022
1LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
01/2022
1relugolixIBA
01/2022
1NPC 16IBA
04/2021

Therapy/Procedure

10Therapeutics
11/2020 - 06/2004
6Hysterectomy
11/2021 - 03/2006
6Drug Therapy (Chemotherapy)
08/2019 - 07/2011
6Cystectomy
11/2016 - 02/2003
4Laparotomy
10/2021 - 10/2008
4Lymph Node Excision (Lymph Node Dissection)
08/2021 - 06/2015
3Aftercare (After-Treatment)
01/2017 - 05/2011
2Cesarean Section (Caesarean Section)
02/2022 - 10/2007
2Neoadjuvant Therapy
01/2021 - 04/2014
2Kampo Medicine (Kampo)
11/2020 - 11/2019
2Art Therapy
01/2019 - 01/2016
1Adjuvant Chemotherapy
02/2022
1Stents
08/2021
1Preoperative Care
08/2021